Boothbay Fund Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-48,320
Closed -$385K – 1759
2025
Q1
$385K Buy
48,320
+34,349
+246% +$347K 0.01% 962
2024
Q4
$127K Buy
13,971
+622
+5% +$6K ﹤0.01% 1254
2024
Q3
$123K Sell
13,349
-429
-3% -$3.55K ﹤0.01% 1436
2024
Q2
$135K Sell
13,778
-6,542
-32% -$79.8K ﹤0.01% 1329
2024
Q1
$307K Buy
+20,320
New +$369K 0.01% 1182
2023
Q2
– Sell
-15,741
Closed -$408K – 2280
2023
Q1
$408K Buy
15,741
+4,770
+43% +$128K 0.01% 1347
2022
Q4
$259K Buy
10,971
+2,370
+28% +$63.9K 0.01% 1466
2022
Q3
$218K Buy
+8,601
New +$302K 0.01% 1773
2022
Q1
– Sell
-2,668
Closed -$245K – 2525
2021
Q4
$245K Buy
+2,668
New +$319K 0.01% 1364
2017
Q1
– Sell
-10,592
Closed -$175K – 939
2016
Q4
$175K Buy
+10,592
New +$180K 0.04% 624

Other funds holding TDOC

Boothbay Fund Management's TDOC Position: Q2 2025 in Review

Boothbay Fund Management sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 48,320 shares — an estimated $385K sold.

Boothbay Fund Management first reported a position in TDOC in Q4 2016 and held it in 10 quarters. The position peaked at $408K in Q1 2023. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Boothbay Fund Management reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 48,320 Teladoc Health shares in Q2 2025, an estimated $385K.
  • Boothbay Fund Management first reported a position in Teladoc Health in Q4 2016 and held it in 10 quarters.
  • Boothbay Fund Management's Teladoc Health position peaked at $408K in Q1 2023.
  • 359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Boothbay Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.